Market Overview

Medtronic Comments on Crystal AF Clinical Trial; Says Device Detects More Erratic Heart Rhythms Than Standard

Share:
Related MDT
Medtronic Adds New Resolute Onyx Drug-Eluting Stent Sizes, and Expands Indications
Are Share Repurchases On The Horizon?

Posted-In: News FDA

 

Related Articles (MDT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters